Adrenal disease

Cardiometabolic Risk in Bilateral versus Unilateral Nonfunctioning Adrenal Incidentalomas: Evidence From a Large Referral Center Cohort

Endocr PractPublished Retrospective cross-sectional study

Authors' conclusion

Bilateral NFAIs are independently associated with greater cardiometabolic risk and complications compared to unilateral lesions.

Study context

Population
Outpatients with nonfunctioning adrenal incidentalomas (NFAIs) in primary cardiovascular prevention, diagnosed and treated at a tertiary referral center 2000–2024
Participants
906 outpatients
Exposure
Bilateral vs unilateral NFAIs
  • Bilateraln = 86
  • Unilateraln = 820reference
Outcome
Cardiovascular risk assessed using validated scores
Methodological detailssingle-centre, tertiary referral center
  • Single-centre
  • Tertiary referral center

Main finding

As reported in the abstract

Cardiovascular risk scores (multivariable linear regression)
  • Bilateral vs Unilateral: P = 0.006
  • Bilateral vs Unilateral: P < 0.001
  • Bilateral vs Unilateral: P < 0.001
  • Bilateral vs Unilateral: P = 0.035
  • Multivariable linear regressions

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Presence of T2D2.36 (1.18–4.72)P = 0.015
Presence of organ damage2.09 (1.00–4.37)P = 0.050
  • Presence of T2D: multivariable logistic regression adjusted for age, male sex, BMI, smoking, arterial hypertension, number of antihypertensive drugs and eGFR
  • Presence of organ damage: multivariable logistic regression adjusted for age, male sex, BMI, smoking, arterial hypertension and number of antihypertensive drugs

Original publication

Cardiometabolic Risk in Bilateral versus Unilateral Nonfunctioning Adrenal Incidentalomas: Evidence From a Large Referral Center Cohort. Endocr Pract. Published 23 March 2026. doi:10.1016/j.eprac.2026.03.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.